United States Suboxone Market Is Driven By Increasing Opioid Addiction Rates

By Author: Ben
Total Articles: 165
Comment this article

The United States Suboxone market has seen significant growth in recent years due to the rising opioid addiction rates in the country. Suboxone, containing buprenorphine and naloxone, is a medication used to treat opioid addiction. It helps in managing withdrawal symptoms from opioids like heroin and prescription painkillers. According to estimates, around 2.1 million Americans suffered from opioid abuse disorders involving prescription pain relievers and heroin in 2016.

United States of America Suboxone market is estimated to be valued at US$ 2,285.5 Mn in 2024 and is expected to exhibit a CAGR of 4.1% over the forecast period 2024-2031.

Key players operating in the United States Suboxone market are Indivior PLC., Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals LLC., Mylan N.V., Novartis AG, Teva Pharmaceutical Industries Ltd., Mallinckrodt, Lannett Co Inc., Sun Pharmaceutical Industries Ltd., and Alkem Labs.

Key Takeaways

Key players operating in the United States America Suboxone market are focusing on expanding their product portfolios and manufacturing facilities to cater to the growing ...
... demand. For instance, in 2021, Indivior PLC received US FDA approval for expanded indication of SUBLOCADE for moderate-to-severe opioid use disorder.

The growing abuse of prescription opioids and illicit drugs such as heroin in the US has fueled the demand for addiction treatment drugs like Suboxone. According to National Survey on Drug Use and Health, around 8.5 million adults misused opioids in 2020, showing an increased need for prescription medication-assisted treatment.

Major players are also focusing on global expansion to tap foreign markets and boost revenue streams. For example, in 2021, Dr. Reddy's Laboratories launched generic Suboxone sublingual film in Canada and Europe as part of its international markets growth plan.

Market Drivers

One of the major drivers for the US Suboxone market is the increasing approval and launch of generic versions. As Suboxone goes off patent between 2022-2023, many generic drugmakers are launching affordable substitutes. This is expected to increase accessibility and adoption rates. According to IQVIA, annual spending on generic Suboxone films grew from around $400 million in 2019 to $924 million until June 2021.

The geopolitical situation is significantly impacting the growth of the United States of America Suboxone market. With rising prevalence of opioid use disorder in the country, demand for treatment and medication like Suboxone has increased over the years. However, the current political uncertainty and trade tensions between US and other countries is disrupting supply chains and availability of raw materials required for manufacturing Suboxone. This includes buprenorphine and naloxone which are majorly imported from countries like China and India. Any restrictions or sanctions on trade could negatively affect the steady supply and manufacturing of Suboxone in the US.

Furthermore, budgetary revisions and changes in healthcare policies by the current administration have also led to reduced funding and support for substance abuse treatment programs. This is limiting greater access to medication assisted treatment involving Suboxone for many patients suffering from opioid addiction. To counter such challenges in the coming years, manufacturers will need to diversify their sourcing networks and establish local partnerships to minimize import dependencies. They also need to undertake strategic pricing initiatives and direct patient advocacy efforts to get Suboxone included in more government-sponsored insurance plans and treatment facilities.

Geographically, the Northeast region of the US including states like New York, New Jersey, Pennsylvania, Massachusetts etc. accounts for the largest market share currently in terms value sales of Suboxone. This is because opioid overdose rates and prescription volumes have been highest historically in this area comprising the East Coast states. The South Central region encompassing Texas, Oklahoma, Arkansas is emerging as the fastest growing regional market for Suboxone. Factors such as growing Hispanic population susceptible to opioid misuse coupled with increasing healthcare infrastructure are facilitating wider adoption of medication assisted treatment involving Suboxone here.

What Are The Key Data Covered In This United States of America Suboxone Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the United States of America Suboxone's growth between 2024 and 2031.

:- Accurate calculation of the size of the United States of America Suboxone and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- United States of America Suboxone Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of United States of America Suboxone vendors

FAQ’s

Q.1 What are the main factors influencing the United States of America Suboxone?

Q.2 Which companies are the major sources in this industry?

Q.3 What are the market’s opportunities, risks, and general structure?

Q.4 Which of the top United States of America Suboxone companies compare in terms of sales, revenue, and prices?

Q.5 Which businesses serve as the United States of America Suboxone’s distributors, traders, and dealers?

Q.6 How are market types and applications and deals, revenue, and value explored?

Q.7 What does a business area’s assessment of agreements, income, and value implicate?

Get more insights on this topic: https://benstiller.hashnode.dev/the-us-suboxone-market-to-boom-owing-to-rising-prevalence-of-opioid-use-disorder

Author Bio:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)